Asthma Drug Fluticasone Furoate Fails as Potential COVID Treatment

THURSDAY, July 14, 2022 -- The asthma drug fluticasone furoate is yet another medication that doesn ' t work for mild-to-moderate COVID-19, a new study finds. " There was no evidence of improvement in time to recovery or reduction in hospitalizations...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news